Skip to content

Clinical study on prevention of propofol injection pain by TAES combined with lidocaine

Clinical study on prevention of propofol injection pain by TAES combined with lidocaine

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036066
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Propofol injection pain

Interventions

Sponsors

Department of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 18 to 65 years who were selected for painless hysteroscopy; 2. ASA grade I-II; 3. BMI kg/m2 18-31; 4. No contraindication of propofol and lidocaine; 5. informed consent to this pre-treatment programme.

Exclusion criteria

Exclusion criteria: 1. meridian points have surgical incision or scar; 2. patients with local skin infection at acupoints; 3. patients with upper or lower limb nerve damage; 4. have a history of spinal surgery; 5. other clinical trials in the last four weeks; 6. can't understand NRS score; 7. patients with history of allergy to lipids, propofol, local anesthetics (lidocaine) and general anesthesia; 8. patients with forearm thrombophlebitis or acute and chronic pain syndrome; 9. has a history of gastrointestinal ulcers and analgesic and sedative drug abuse; 10. Severe mental illness or Patients with dyslexia; 11. Patients with chronic pain syndrome, thrombophlebitis, neurological disorders; 12. The researchers found it inappropriate to participate in the trial.

Design outcomes

Primary

MeasureTime frame
VAS;

Countries

China

Contacts

Public ContactMo Yunchang

Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University

89504121@qq.com+86 13506666165

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026